THBD and COVID-19: Although our study does not directly conclude on the incidence of coagulopathies in either COVID-19 or sepsis patients, possible tissue damage could have contributed to changes observed in the coagulation cascade, where all proteins altered during COVID-19 (vWF, thrombomodulin, Factor XIII and Factor VIII) are linked to injury and wound repair [34–36].